ITGA6-AS1, as an antisense non-coding RNA of ITGA6, can specifically target ITGA6 and lead to its increased expression, thereby regulating the occurrence and aggressiveness of breast cancer and secondary plasmacytic leukaemia 23 (Figure 7B). This evidence concerns the gene ITGA6 and breast carcinoma.